TIAA FSB’s Adaptive Biotechnologies ADPT Stock Holding History

TIAA FSB’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,008	Closed	-$203K	–	573
2023 Q1	$203K	Buy	23,008 +33	+0.1%	+$291	﹤0.01%	538
2022 Q4	$176K	Sell	22,975 -4,000	-15%	-$31.1K	﹤0.01%	548
2022 Q3	$192K	Sell	26,975 -1,000	-4%	-$9.42K	﹤0.01%	542
2022 Q2	$226K	Hold	27,975	–	–	﹤0.01%	535
2022 Q1	$388K	Hold	27,975	–	–	﹤0.01%	349
2021 Q4	$785K	Hold	27,975	–	–	﹤0.01%	322
2021 Q3	$951K	Sell	27,975 -2,425	-8%	-$87.7K	﹤0.01%	307
2021 Q2	$1.24M	Buy	+30,400	New	+$1.18M	﹤0.01%	300

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

TIAA FSB's ADPT Position: Q2 2023 in Review

TIAA FSB sold out of Adaptive Biotechnologies (ADPT) in Q2 2023, closing a stake of 23,008 shares — an estimated $203K sold.

TIAA FSB first reported a position in ADPT in Q2 2021 and held it in 8 quarters. The position peaked at $1.24M in Q2 2021. 210 funds tracked by Wall St. Rank hold ADPT as of Q2 2023.

TIAA FSB reported no remaining Adaptive Biotechnologies position as of Q2 2023 after selling out during the quarter.
TIAA FSB sold 23,008 Adaptive Biotechnologies shares in Q2 2023, an estimated $203K.
TIAA FSB first reported a position in Adaptive Biotechnologies in Q2 2021 and held it in 8 quarters.
TIAA FSB's Adaptive Biotechnologies position peaked at $1.24M in Q2 2021.
210 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.